The Regulatory Affairs and Compliance team at Sionna Therapeutics is responsible for ensuring that the company's novel small molecule therapies for cystic fibrosis meet all regulatory requirements and industry standards. This team works closely with various departments to manage submissions to regulatory agencies, maintain compliance with laws and regulations, and navigate the approval process, ensuring the timely and safe introduction of therapies to the market.
Adam Rosenberg
Director
Andy Chu
VP, Information & Technology
Bruce Booth
Director
Erica Iorio
Senior Director, Corporate Con...
James Petersen
Associate Director, Assistant ...
Jamie Kistner
Senior Director Data Managemen...
Josh Resnick
Director
Lucian Iancovici
Director
Mara Furlow
VP, Global Regulatory Affairs
Peter Thompson
Director
View all